Home Neurological Disorders Parkinsons

Parkinsons

Latest
Gut–brain axis. The gut-brain connection.
Parkinsons

No Appendix Equals Decreased Parkinson’s Risk

Parkinsons

European Consortium Wins €3.7M to Develop, Study Models of Neurological Disorders

Parkinsons

Parkinson’s Disease Drug That Cools “Brains on Fire” Could Enter Human...

Amyloid/Muscle
Parkinsons

Amyloids Shown to Also Play Beneficial Role in Developing Healthy Muscle...

Source: Pixabay
Parkinsons

Parkinson’s Diagnosis Could Be in the Eyes of the Holder

Source: Moussa81/Getty Images
Parkinsons

Parkinson’s Symptoms Associated with Contact Sports

GlaxoSmithKline (GSK) has made a $300 million equity investment in 23andMe under a collaboration designed to accelerate development of new therapies for both companies by using genetic data to identify new drug targets. [Source: © fotoliaxrender/Fotolia]
Parkinsons

GSK Invests $300M in 23andMe as Companies Collaborate on Drug Development

The role of tau and MAP6 in regulating the stable (green) and dynamic (red) parts of a neuron's microtubules. Depleting tau from cultured rat neurons led to greater stability of the neuron's microtubules. [Drexel University]
Parkinsons

Alzheimer’s Drugs Targeting Tau May Actually Exacerbate Disease

Mitochondria stained in neurons [Mathew Horocks/University of Cambridge
Parkinsons

Parkinson’s Protein Transition Provides Insight into Disease Progression

Source: Pixabay
Parkinsons

Parkinson’s Risk Decreased among Immunosuppressant Users

Load more

Recently Featured

Stay Connected

557,680FansLike
45,824FollowersFollow
Copyright © 2019 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up